feed,title,long_url,short_url
Benzinga,A Look Into AstraZeneca's Price Over Earnings,https://benzinga.com/news/earnings/21/03/20169199/a-look-into-astrazenecas-price-over-earnings,https://j.mp/3eH9mPo
Benzinga,P/E Ratio Insights for Sensata Technologies,https://benzinga.com/news/earnings/21/03/20169242/pe-ratio-insights-for-sensata-technologies,https://j.mp/3bLiQqP
Benzinga,P/E Ratio Insights for JPMorgan Chase,https://benzinga.com/news/earnings/21/03/20169263/pe-ratio-insights-for-jpmorgan-chase,https://j.mp/38II2w7
Benzinga,P/E Ratio Insights for Barnes,https://benzinga.com/news/earnings/21/03/20169376/pe-ratio-insights-for-barnes,https://j.mp/3bNWS6r
Benzinga,"Equillium's Stock Is Trading Higher On Itolizumab's Durable, Sustained Response In Graft-Versus-Host Disease Study",https://benzinga.com/general/biotech/21/03/20168725/equilliums-stock-is-trading-higher-on-itolizumabs-durable-sustained-response-in-graft-versus-host,https://j.mp/38JtrR0
